All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YC0776 | Human anti-OR14C36 T cell receptor (AA1), pCDTCR1 | AA1 | Human | FMLYLLTLM | HLA-A2 | Lentiviral vector | ||
TCR-YC0777 | Human anti-OR14C36 T cell receptor (GA6), pCDTCR1 | GA6 | Human | FMLYLLTLM | HLA-A2 | Lentiviral vector | ||
TCR-YC0778 | Human anti-OR14C36 T cell receptor (GB4), pCDTCR1 | GB4 | Human | FMLYLLTLM | HLA-A2 | Lentiviral vector | ||
TCR-YC0779 | Human anti-OR14C36 T cell receptor (IA2), pCDTCR1 | IA2 | Human | FMLYLLTLM | HLA-A2 | Lentiviral vector | ||
TCR-YC0780 | Human anti-OR14C36 T cell receptor (JB3), pCDTCR1 | JB3 | Human | FMLYLLTLM | HLA-A2 | Lentiviral vector | ||
TCR-YC0781 | Human anti-OR14C36 T cell receptor (JG7), pCDTCR1 | JG7 | Human | FMLYLLTLM | HLA-A2 | Lentiviral vector | ||
TCR-YC0782 | Human anti-OR14C36 T cell receptor (JH11), pCDTCR1 | JH11 | Human | FMLYLLTLM | HLA-A2 | Lentiviral vector | ||
TCR-YC0783 | Human anti-OR14C36 T cell receptor (MC10), pCDTCR1 | MC10 | Human | FMLYLLTLM | HLA-A2 | Lentiviral vector | ||
TCR-YC0784 | Human anti-OR14C36 T cell receptor (MD12), pCDTCR1 | MD12 | Human | FMLYLLTLM | HLA-A2 | Lentiviral vector | ||
TCR-YC0785 | Human anti-OR14C36 T cell receptor (MF8), pCDTCR1 | MF8 | Human | FMLYLLTLM | HLA-A2 | Lentiviral vector | ||
TCR-YC0786 | Human anti-OR14C36 T cell receptor (NC3), pCDTCR1 | NC3 | Human | FMLYLLTLM | HLA-A2 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION